Pfizer Inc
NYSE:PFE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pfizer Inc
NYSE:PFE
|
US |
|
Equifax Inc
NYSE:EFX
|
US |
|
S
|
Samart Corporation PCL
SET:SAMART
|
TH |
|
Nick Scali Ltd
ASX:NCK
|
AU |
|
I
|
Industrie De Nora SpA
MIL:DNR
|
IT |
|
UBS Group AG
SIX:UBSG
|
CH |
|
Zai Lab Ltd
HKEX:9688
|
CN |
|
E
|
Equity LifeStyle Properties Inc
NYSE:ELS
|
US |
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
SA |
|
Puradelta Lestari Tbk PT
IDX:DMAS
|
ID |
|
Telefonaktiebolaget LM Ericsson
STO:ERIC B
|
SE |
|
Rayonier Advanced Materials Inc
NYSE:RYAM
|
US |
|
A
|
Archer-Daniels-Midland Co
XETRA:ADM
|
US |
|
JSR Corp
TSE:4185
|
JP |
Wall St Price Targets
PFE Price Targets Summary
Pfizer Inc
According to Wall Street analysts, the average 1-year price target for PFE is 29.57 USD with a low forecast of 24.24 USD and a high forecast of 37.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PFE's stock price target?
Price Target
29.57
USD
According to Wall Street analysts, the average 1-year price target for PFE is 29.57 USD with a low forecast of 24.24 USD and a high forecast of 37.8 USD.
What is the Revenue forecast for Pfizer Inc?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is -1%.
What is the Operating Income forecast for Pfizer Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is -2%.
What is the Net Income forecast for Pfizer Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 8 years is 9%.
